Neutrophil disorders and their management

Journal of Clinical Pathology

Volumn 54, Issue 1, 2001, Pages 7-19

  Lakshman, R ^a   Finn, A ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Chronic granulomatous disease; Neutrophil chemotaxis; Neutrophil disorders; Phagocytosis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIBIOTIC PROPHYLAXIS; BONE MARROW TRANSPLANTATION; CHEDIAK HIGASHI SYNDROME; CHILDHOOD DISEASE; CHRONIC GRANULOMATOUS DISEASE; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; HUMAN; INFANT DISEASE; INFECTION; INFECTIOUS COMPLICATION; LEUKOCYTE ADHERENCE; LEUKOCYTE FUNCTION; MORBIDITY; MORTALITY; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REVIEW;

CHEMOTAXIS, LEUKOCYTE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; NEUTROPENIA; NEUTROPHILS;

EID: 0035166624     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.1.7     Document Type: Review

References (130)

1. Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion
2. Transcytosis and surface presentation of IL-8 by venular endothelial cells
3. Human chemokines: An update
4. Novel trends in neutrophil structure, function and development
5. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis
6. Reference values
7. Pseudoneutropenia in negroes: A normal phenomenon
8. Diagnosis and management of chronic neutropenia during childhood
9. Chronic neutropenia during childhood. A 13-year experience in a single institution
10. Infantile genetic agranulocytosis. A review with presentation often new cases
11. Dominantly inherited severe congenital neutropenia
12. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia
13. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia
14. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation
15. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment
16. Congential neutropenia: Abnormal neutrophil differentiation associated with HLA
17. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
18. Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia
19. Severe congenital neutropenia terminating in acute myeloid leukemia: Disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene
20. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon
21. Congenital agranulocytosis: Prolonged survival and terminal acute leukemia
22. Congenital agranulocytosis terminating in acute myelomonocytic leukemia
23. Severe congenital neutropenia: Abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor
24. Thymic alymphoplasia and congenital aleukocytosis (reticular dysgenesia)
25. Cyclic neutropenia. A tale of two brothers and their family
26. Cyclic neutropenia in identical twins
27. Cyclic hematopoiesis: Human cyclic neutropenia
28. Oscillations of granulocytic and megakaryocytic progenitor cell populations in cyclic neutropenia in man
29. Periodic hematopoiesis in human cyclic neutropenia
30. Cyclic neutropenia in a family with evidence of monocytes, lymphocytes, plasmocytes, eosinophils and basophils cycling
31. Cyclic neutropenia: A clinical review
32. Human cyclic neutropenia transferred by allogeneic bone marrow grafting
33. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis
34. Clostridium septicum infection in children with cyclic neutropenia
35. Cyclic neutropenia - Unusual cause of acute abdomen. Report of a case
36. Cyclic neutropenia with colonic perforation and nonhealing colocutaneous fistula
37. Familial cyclical neutropenia
38. Natural history of primary autoimmune neutropenia in infancy
39. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia
40. Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases
41. The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies
42. Chronic idiopathic and secondary neutropenia: Clinical and serological investigations
43. Auto-immune neutropenia
44. Report on the second international granulocyte serology workshop
45. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia
46. Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia
47. Infectious and bleeding complications in patients with glycogenosis Ib
48. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib
49. Haematological abnormalities in Shwachman-Diamond syndrome
50. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)
51. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)
52. Barth syndrome: Clinical features and confirmation of gene localisation to distal Xq28
53. Autosomal recessive onychotrichodysplasia, chronic neutropenia and mild mental retardation. Delineation of the syndrome
54. CD40 ligand deficiency presenting as unresponsive neutropenia
55. Clinical spectrum of X-linked hyper-IgM syndrome
56. Neutropenia in X-linked agammaglobulinemia
57. Antimicrobial prophylaxis
58. Increases in neutrophil counts by purified human urinary colony-stimulating factor in chronic neutropenia of childhood
59. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis
60. Pathophysiology and treatment of severe chronic neutropenia
61. Severe congenital neutropenia: Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor
62. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia
63. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia
64. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias
65. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with chronic benign granulocytopenia and congenital agranulocytosis (Kostmann's syndrome)
66. The effect of continuous G-CSF application in human cyclic neutropenia: A model analysis
67. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: Use of a new 3-day-a-week regimen
68. Intermittent rG-CSF treatment in cyclic neutropenia
69. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia
70. Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia
71. Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor
72. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor
73. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients
74. Autoimmune neutropenia
75. The use of rhG-CSF in chronic autoimmune neutropenia: Reversal of autoimmune phenomena, a case history
76. Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF)
77. Granulocyte colony stimulating factor treatment for neonatal neutropenia
78. Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy
79. New developments in the treatment of neutropenia
80. Use of intravenous immunoglobulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia
81. Efficacy of intravenous gamma globulin in autoimmune mediated blood dyscrasias
82. Severe congenital neutropenia unresponsive to G-CSF
83. Successful bone-marrow transplantation for reticular dysgenesis
84. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease (the international chronic granulomatous disease cooperative study group)
85. Trimethoprimsulfamethoxazole prophylaxis in the management of chronic granulomatous disease
86. Clinical features and current management of chronic granulomatous disease
87. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils
88. Chronic granulomatous disease
89. Chronic granulomatous disease
90. Prognosis of chronic granulomatous disease
91. Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays
92. Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry
93. RFLP and deletion analysis for X-linked chronic granulomatous disease using the cDNA probe: Potential for improved prenatal diagnosis and carrier determination
94. The management of chronic granulomatous disease
95. Long-term itraconazole prophylaxis against aspergillus infections in thirty-two patients with chronic granulomatous disease
96. Interferon gamma for chronic granulomatous disease
97. Recombinant human interferon-gamma in patients with chronic granulomatous disease - European follow up study
98. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils
99. Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease
100. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease
101. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B
102. Myeloperoxidase deficiency: Prevalence and clinical significance
103. LFA-1 immunodeficiency disease. Definition of the genetic defect and chromosomal mapping of alpha and beta subunits of the lymphocyte function-associated antigen 1 (LFA-1) by complementation in hybrid cells
104. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1
105. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins
106. Recurrent infections and delayed separation of the umbilical cord in an infant with abnormal phagocytic cell locomotion and oxidative response during partial phagocytosis
107. Pyoderma gangrenosum in a child with congenital partial deficiency of leucocyte adherence glycoproteins
108. Disorders of the polymorphonuclear phagocytic system
109. Measurement of adhesion molecule expression on neutrophils and fixation
110. Molecular basis of leukocyte adhesion deficiency
111. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency
112. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism
113. In vivo neutrophil and lymphocyte function studies in a patient with leukocyte adhesion deficiency type II
114. Hyper-IgE syndrome with recurrent infections - An autosomal dominant multisystem disorder
115. Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome
116. Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections
117. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
118. Association of low levels of mannan-binding protein with a common defect of opsonisation
119. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children
120. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections
121. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils
122. Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers
123. Saliva: A convenient source of DNA for analysis of bi-allelic polymorphisms of Fc gamma receptor IIA (CD32) and Fc gamma receptor IIIB (CD16)
124. Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43
125. Chediak-Higashi syndrome
126. Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): Studies in humans and mice
127. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: Report of 10 cases
128. Polymorphonuclear granulocyte expression of CD11a/CD18, CD11b/CD18 and L-selectin in normal individuals
129. Assessment of neutrophil function